Saurabh Singhal

Dr. Saurabh Singhal

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2020 in Esophagus
Verified
Journal Article
Closed access
PDF file
TTTania Triantafyllou
Tania Triantafyllou
MOMichael T. Olson
Michael T. Olson
DTDimitrios Theodorou
Dimitrios Theodorou
DSDimitrios Schizas
Dimitrios Schizas
SSSaurabh Singhal
Saurabh Singhal

19 November 2008 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
JSJ. B. Sharma
J. B. Sharma
SAShena Aggarwal
Shena Aggarwal
SSSaurabh Singhal
Saurabh Singhal
SKS. Kumar
S. Kumar
KRK. K. Roy
K. K. Roy

5 July 2017 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
SSSaurabh Singhal
Saurabh Singhal
DKDaniel R. Kirkpatrick
Daniel R. Kirkpatrick
TMTakahiro Masuda
Takahiro Masuda
JGJanese Gerhardt
Janese Gerhardt
SMSumeet K. Mittal
Sumeet K. Mittal

1 July 2018 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
TTTania Triantafyllou
Tania Triantafyllou
PAPiyush Aggarwal
Piyush Aggarwal
EGEkansh Gupta
Ekansh Gupta
WSWendy Jo Svetanoff
Wendy Jo Svetanoff
DBDeepak Prakash Bhirud
Deepak Prakash Bhirud
SSSaurabh Singhal
Saurabh Singhal
Background & Aims: Transjugular Intrahepatic Portosystemic Shunt (TIPS) is used to control refractory variceal bleeding secondary to portal hypertension. This meta-analysis was conducted to systematically review polytetrafluoroethylene-covered stent grafts (CS) versus bare stents (BS) in TIPS procedure. Methods: Systematic search of literature databases was done from January-1990 till April-2017, using predecided keywords. Outcome measures studied were (1) primary-patency (PP) at 1 year (defined as absence of shunt insufficiency at 1 year), (2) rebleeding (RE) (3) new-onset hepatic encephalopathy ([HE] new-onset or worsening encephalopathy following the procedure), and (4) survival at 1 year (SU). Odds ratio (OR) was calculated for each outcome variable. Between-study heterogeneity was assessed by the I2 statistics and χ2 Q-test. Results: Fourteen studies (4 RCTs, 2 prospective nonrandomized, and 8 retrospective) were included with 2519 patients (1548 patients in BS group and 971 patients in CS group). Three-quarter outcome measures showed significantly better results with CS. PP was pooled from 13 studies and showed an OR = 4.75 (95% confidence interval [CI] = 3.32–6.79; P < .00001; I2 = 44%) in favor of CS. RE was pooled from six studies with odds ratio (OR) = 0.37(95% CI = 0.24–0.56; P < .00001; I2 = 0%) in favor of CS. SU was pooled from 11 studies with OR = 1.85 (95% CI = 1.44–2.38; P < .00001; I2 = 0%) in favor of CS. On subset analysis for RCTs, three outcome variables favored CS with minimal heterogeneity [PP: OR = 4.18 (95% CI = 2.66–6.55; P < .00001; I2 = 0%). RE: OR = 0.43 (95% CI = 0.25–0.72; P < .001; I2 = 0%). SU: OR = 1.85 (95% CI = 1.44–2.38, P < .00001; I2 = 0%)]. HE showed no difference between two stents on the overall and subset pooled analysis. Overall: OR = 0.86 (95% CI = 0.68–1.08; P = .19; I2 = 4%). Only RCTs: OR = 0.91 (95% CI = 0.63–1.32, P = .63; I2 = 0%). Conclusions: CS is associated with better primary patency and survival and lesser rate of rebleeding than BS in patients undergoing TIPS procedure. There is no difference in new-onset hepatic encephalopathy.

1 August 2018 in The American Journal of Surgery
Verified
Journal Article
Closed access
ABAlison E. Brandeis
Alison E. Brandeis
SSSaurabh Singhal
Saurabh Singhal
TLTommy H. Lee
Tommy H. Lee
SMSumeet K. Mittal
Sumeet K. Mittal

23 May 2017 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
SAS. Akimoto
S. Akimoto
SSSaurabh Singhal
Saurabh Singhal
TMT. Masuda
T. Masuda
SMS. K. Mittal
S. K. Mittal
We propose a new classification for esophagogastric junction (EGJ) incorporating both physiologic and morphologic characteristics. Additionally, we contrast it with the Chicago v 3.0 EGJ classification. With Institutional Review Board (IRB) approval, prospectively maintained database was queried to identify patients who underwent high-resolution manometry (HRM) and pH-study between October 2011 and October 2015. Patients with prior foregut intervention, pH study on acid suppression, esophageal dysmotility, or lower esophageal sphincter–crural diaphragm separation of >5 cm were excluded. We classified patients into three groups—Type-A: Complete overlap of lower esophageal sphincter–crural diaphragm (single high-pressure zone); Type-B: Double high-pressure zone with pressure inversion point (PIP) at or above lower esophageal sphincter; Type-C: Double high-pressure zone with PIP below lower esophageal sphincter. A total of 214 included patients were divided into Type-A (n = 101), Type-B (n = 32), and Type-C (n = 81). Abdominal lower esophageal sphincter length (AL), lower esophageal sphincter pressure (LESP), and lower esophageal sphincter pressure integral (LESPI) were significantly lower in Type-C than both Type-A and Type-B [AL(cm): 0.2 vs. 2(P < 0.001) vs. 1.6(P <0.001); LESP(mmHg): 20.1 vs. 32.1(P < 0.001) vs. 29.2(P < 0.001); LESPI(mmHg.cm.s): 187 vs. 412(P < 0.001) vs. 343(P < 0.05)] while overall lower esophageal sphincter length(OL) and Integrated Relaxation Pressure (IRP) were significantly lower in Type-C than Type-A [OL(cm): 2.9 vs. 3.6(P < 0.001); IRP(mmHg): 8.2 vs. 9.6(P < 0.05)]. Type-C patients had significantly higher positive pH score (>14.7) than Type-A and Type-B [72% vs. 47% (P < 0.05) vs. 41% (P < 0.001)]. In Type-C morphology, there is both anatomical and physiological deterioration, weakest lower esophageal sphincter function (abdominal length, lower esophageal sphincter pressure, and lower esophageal sphincter pressure integral) and is most likely to be associated with pathological reflux. This proposed classification incorporates both physiological and morphological derangements in a graded fashion.